-
Something wrong with this record ?
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic
D. Leonardi Vinci, A. Meccio, A. Provenzani, ME. Faggiano, N. Miljković, D. Makridaki, P. Horák, P. Polidori
Language English Country Great Britain
Document type Journal Article
NLK
PubMed Central
from 2016
Europe PubMed Central
from 2016 to 1 year ago
ProQuest Central
from 2012-02-01 to 6 months ago
Health & Medicine (ProQuest)
from 2012-02-01 to 6 months ago
- MeSH
- COVID-19 * MeSH
- Hospitalization MeSH
- Humans MeSH
- Pandemics * MeSH
- Critical Care MeSH
- SARS-CoV-2 MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVE: To create an informatics supportive tool, which can assist healthcare professionals in estimating potential requirements for essential drug supplies to respond to the current SARS-CoV-2 pandemic based on epidemiological forecasting. METHODS: The tool was based on a Susceptible-Infected-Removed (SIR) epidemiological model in which the population is divided into three compartments and transmission parameters are specified to define the rate at which people move between stages. Appropriate data entry was guaranteed by the creation of structured guided paths. The drugs needed for the forecasted patients were estimated according to a list of critical care drugs compiled by consulting previous published scientific works, national and international guidelines. For each drug, an estimation was made of the percentage average ICU uptake for each therapeutic group and active principle. RESULTS: The tool consists of a Microsoft Excel template that is based on the initial epidemiological situation, the non-pharmaceutical interventions applied, the risk of hospitalisation based on the population age distribution, and the hospital beds available. The tool provides a forecast of which patients with COVID-19 will need to be treated in a hospital setting. The number of patients is used to estimate the drugs needed based on the average daily dose and the treatment length of each drug. The possibility of editing the type of distribution (exponential or linear) of the number of patients at the beginning of the analysis, the percentage adherence with non-pharmaceutical interventions and their delayed effect, and all the key epidemiological parameters make the estimation tailorable to different clinical contexts and needs. CONCLUSIONS: This model might be an effective supporting tool that could be easily implemented within the workflow of health professionals. All the information reported in this paper could be useful in developing new strategies to tackle the COVID-19 pandemic.
Chemical Engineering University of Palermo Palermo Sicilia Italy
Clinical Pharmacy ISMETT Palermo Italy
Hospital Pharmacy Institute of Orthopaedic Surgery Banjica Belgrade Serbia
Hospital Pharmacy Motol University Hospital Praha Praha Czech Republic
Pharmacy AOU Policlinico Bari Puglia Italy
Pharmacy Services Sismanoglio Amalia Fleming General Hospital of Attica Athens Greece
School of Specialization in Hospital Pharmacy University of Palermo Palermo Sicilia Italy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010852
- 003
- CZ-PrNML
- 005
- 20220506131503.0
- 007
- ta
- 008
- 220425s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/ejhpharm-2020-002633 $2 doi
- 035 __
- $a (PubMed)33619027
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Leonardi Vinci, Daniele $u School of Specialization in Hospital Pharmacy, University of Palermo, Palermo, Sicilia, Italy daniele.leo93@gmail.com $1 https://orcid.org/0000000343833726
- 245 14
- $a The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic / $c D. Leonardi Vinci, A. Meccio, A. Provenzani, ME. Faggiano, N. Miljković, D. Makridaki, P. Horák, P. Polidori
- 520 9_
- $a OBJECTIVE: To create an informatics supportive tool, which can assist healthcare professionals in estimating potential requirements for essential drug supplies to respond to the current SARS-CoV-2 pandemic based on epidemiological forecasting. METHODS: The tool was based on a Susceptible-Infected-Removed (SIR) epidemiological model in which the population is divided into three compartments and transmission parameters are specified to define the rate at which people move between stages. Appropriate data entry was guaranteed by the creation of structured guided paths. The drugs needed for the forecasted patients were estimated according to a list of critical care drugs compiled by consulting previous published scientific works, national and international guidelines. For each drug, an estimation was made of the percentage average ICU uptake for each therapeutic group and active principle. RESULTS: The tool consists of a Microsoft Excel template that is based on the initial epidemiological situation, the non-pharmaceutical interventions applied, the risk of hospitalisation based on the population age distribution, and the hospital beds available. The tool provides a forecast of which patients with COVID-19 will need to be treated in a hospital setting. The number of patients is used to estimate the drugs needed based on the average daily dose and the treatment length of each drug. The possibility of editing the type of distribution (exponential or linear) of the number of patients at the beginning of the analysis, the percentage adherence with non-pharmaceutical interventions and their delayed effect, and all the key epidemiological parameters make the estimation tailorable to different clinical contexts and needs. CONCLUSIONS: This model might be an effective supporting tool that could be easily implemented within the workflow of health professionals. All the information reported in this paper could be useful in developing new strategies to tackle the COVID-19 pandemic.
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a péče o pacienty v kritickém stavu $7 D003422
- 650 _2
- $a hospitalizace $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a pandemie $7 D058873
- 650 _2
- $a SARS-CoV-2 $7 D000086402
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Meccio, Adriano $u Chemical Engineering, University of Palermo, Palermo, Sicilia, Italy
- 700 1_
- $a Provenzani, Alessio $u Clinical Pharmacy, ISMETT, Palermo, Italy
- 700 1_
- $a Faggiano, Maria Ernestina $u Pharmacy, AOU Policlinico, Bari, Puglia, Italy
- 700 1_
- $a Miljković, Nenad $u Hospital Pharmacy, Institute of Orthopaedic Surgery "Banjica", Belgrade, Serbia
- 700 1_
- $a Makridaki, Despina $u Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
- 700 1_
- $a Horák, Petr $u Hospital Pharmacy, Motol University Hospital, Praha, Praha, Czech Republic
- 700 1_
- $a Polidori, Piera $u Clinical Pharmacy, ISMETT, Palermo, Italy $1 https://orcid.org/0000000184969908
- 773 0_
- $w MED00200143 $t European journal of hospital pharmacy : science and practice $x 2047-9956 $g Roč. 29, č. e1 (2022), s. e23-e29
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33619027 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131455 $b ABA008
- 999 __
- $a ok $b bmc $g 1788793 $s 1162050
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 29 $c e1 $d e23-e29 $e 20210222 $i 2047-9956 $m European journal of hospital pharmacy $n Eur J Hosp Pharm $x MED00200143
- LZP __
- $a Pubmed-20220425